Amyloid load (AβL) imaged in vivo using [18F]Florbetapir PET is a more sensitive biomarker for measuring the global amyloid (Aβ) burden compared to composite standardized uptake value ratio (SUVr), reported authors of a Sept. 6 Journal of Nuclear Medicine study.

With a lawsuit challenging the constitutionality of the Affordable Care Act in the hands of a federal judge in Texas, Maryland is taking the issue head on by filing a lawsuit that would keep the healthcare law intact.

An artificial intelligence (AI) system developed by Shinjini Kundu, PhD, a physician and medical researcher at the University of Pittsburgh Medical Center, could find patterns of developing diseases as much as three years earlier than imaging experts.

The Center for Women’s and Children’s Health at Henry Ford Wyandotte Hospital in Wyandotte, Michigan, is celebrating 20 years of providing free mammograms to women in need.

Cigna is launching a venture fund that will be dedicated to investing in companies with innovative and transformative plans for healthcare.

The American Heart Association has tightened its guidelines for diagnosing resistant hypertension—a condition that affects up to 15 percent of patients treated for high blood pressure—according to a scientific statement published this month.

By using the CRISPR gene-editing tool, a research team was able to identify several mutations in cells that boosted the risk of cancer.

Cone-beam breast CT (CBBCT) is an effective imaging modality for assessing a patient’s breast density, according to a new study published in Academic Radiology.

The University of Akron in Ohio will eliminate 80 programs over the next few years, including radiology—leaving students out of luck. Kent State Salem in Ohio believes students will flock to its program as a result, Kentwired.com reported.

Despite national guidelines advising against prostate cancer screening in men 70 or older, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center found that prostate cancer care for this demographic costs Medicare more than $400 million a year, according to a study published Sept. 13 in JAMA Oncology.